Today it was reported that the SVP, Chief Transformation Off of Hill-Rom (HRC), Andreas Frank, exercised options to sell 7,454 HRC shares at $27.89 a share, for a total transaction value of $713.8K.
Following Andreas Frank’s last HRC Sell transaction on September 15, 2017, the stock climbed by 22.1%.
See today’s analyst top recommended stocks >>
Based on Hill-Rom’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $759 million and quarterly net profit of $90.4 million. In comparison, last year the company earned revenue of $738 million and had a net profit of $69.4 million. HRC’s market cap is $6.53B and the company has a P/E ratio of 26.00. Currently, Hill-Rom has an average volume of 480.8K.
Based on 3 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $102.67, reflecting a 5.6% upside.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Hill-Rom Holdings, Inc. is a medical technology company, which focuses on patient care solutions that improve clinical and economic outcomes. It operates through the following business segments: Patient Support System, Front Line Care, and Surgical Solutions.
